We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.20
Bid: 62.20
Ask: 63.40
Change: -0.80 (-1.25%)
Spread: 1.20 (1.929%)
Open: 63.00
High: 63.20
Low: 63.00
Prev. Close: 64.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

29 May 2018 07:47

RNS Number : 4882P
IDOX PLC
29 May 2018
 

 

29 May 2018

Idox plc

 

('Idox' or 'the Group' or 'the Company')

 

Half Year Trading Update

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today issues a trading update for the six months ended 30 April 2018, ahead of its half year results, which are expected to be announced at the end of July. The Group has announced separately today the appointment of a new Chief Executive, David Meaden, subject to completion of the customary regulatory procedures.

 

Overview

A wide ranging operational and financial review of the business has taken place in recent weeks in particular in relation to the Digital division. The Board has taken the actions necessary to resolve the Group's issues and provide a strong base for future growth and it expects these changes will enable the business to deliver improving profitability combined with better cash generation and improving levels of recurring revenue.

 

These actions principally relate to the closure of the Group's lossmaking Digital division, as well as the ongoing alterations to the Engineering division's business model, and the adoption of revised contractual terms in various long term contracts as part of the Group's move to the adoption of IFRS15 for the financial year commencing 1 November 2018 (which governs accounting for revenue from contracts with customers). In addition, the Board has also substantially reorganised divisional reporting lines to both improve accountability and the ability to cross sell the Group's products. 

 

The Board therefore now expects the Group's full year Adjusted EBITDA* to be in the range of £13-15m, including the impact of a c.£5m EBITDA reduction in Digital, compared to current market expectations of around £22.8m. However, the underlying performance excluding the discontinued Digital division is expected to be in the range £18-20m (prior to the effect of cost savings). The majority of these impacts have been incurred in the first half, which will result in Adjusted EBITDA* of c.£1m (H1 2017: £10.3m) for the period.

 

Underlying operating performance in the majority of the Group, including Public Sector and Health, has been as expected with good delivery of the cost savings identified and previously reported, and solid order intake. With the closure of Digital, the reduction to the cost base is now expected to be in excess of £10m on annualised basis (compared to £7m announced in the AGM Trading Update on 19 April 2018).

 

In summary, in future years the Group's financial performance is expected to benefit from a reduced cost base, the rationalisation of Digital, and a stronger commercial focus on recurring revenues and cash conversion.

 

* Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition, corporate finance and share option costs.

 

Chief Executive

The Group has announced separately today the appointment of David Meaden as Chief Executive. David will join Idox on 1 June 2018 subject to completion of the customary regulatory procedure. This is a significant appointment for the Group following the uncertainty over the Group's leadership in the last six months. David's 22 year experience with Northgate Information Solutions where he held Board level leadership roles is especially relevant.

 

Richard Kellett-Clarke, who has been acting as Chief Executive on an interim basis since December 2017 will hand over responsibilities to David Meaden in June and revert to his previous role as a non-executive director at that time. The Board expresses its thanks to Richard who stepped into the role at very short notice and has played an important part in stabilising the business and leading the various business reviews.

 

Digital

It is expected that the continued underperformance and losses of the division combined with anticipated closure costs will depress Adjusted EBITDA* for the year by c.£5m (as stated above). The strongest elements of this business which are focussed on digital delivery of the Group's core local government solutions have been integrated into the Public Sector business. The weaker part which had been focused on lower margin and highly competitive contracts in the private sector is being closed. Digital reported revenues of £14.7m and an adjusted operating loss of £1.5m in the last financial year.

 

Engineering

As previously reported, the Engineering business has been transitioning to a SaaS based model which will result in higher quality, recurring revenue over the longer term. This transition has resulted in short term changes in revenue recognition as a result of an acceleration in the sales of SaaS-based over licensed solutions which have adversely impacted reported financial performance in the division in the first half. As a result, the Group expects revenues in the division for the year to be approximately £1.5 million lower than its prior expectations, but expects higher levels of recurring revenue to be reported in future financial years.

 

Auditor

The Board is pleased to announce that it intends to appoint Deloitte LLP as the Group's new auditors, subject to completion of contracts. They will undertake the review of the Group's half year results, which are expected to be issued later than usual due to this change, in the latter part of July 2018.

 

Cash conversion

The Board has resolved that it is a priority for the Group to improve its cash conversion which has been consistently poor, in part reflecting a large balance of accrued income due to a commercial focus on licence sales rather than long term recurring revenues. Accordingly, the Board has set an annual target of around 100% cash conversion (defined as cash generated from operating activities before tax as a percentage of Adjusted EBITDA). It is expected that significant progress towards this objective will be made in the remainder of this and the next financial year.

 

Financial position

Group net debt at the half year stood at £25.5m (30 April 2017: £28.2m; 31 October 2017: £32.1m).

 

Interim dividend

In light of the lowered expectations for the year and the cash costs incurred in the first half, the Board has decided to suspend the interim dividend. The Board's expects to declare a final dividend for the full year.

 

Outlook

Following the actions taken, an improved performance in the Group's second half is anticipated, with trading in May and June consistent with this. Since the Company's AGM statement in April new contracts have been won with a number of councils (Bexley, Angus, Lichfield, Scottish Borders, Southport & Ormskirk) and NHS trusts (George Eliot, St George's, Abertawe). 

 

Overall, the Board remains confident that the actions taken will strengthen the Group's position and will deliver an improved performance in future years, supported by its high level of recurring and repeating revenues and improving cash conversion.

 

David Meaden said:

"I am delighted to be joining Idox at this very important point in its development. I have known Idox for many years as a leading player in the public sector solutions and services market and am confident that it has both attractive products and talented people. I look forward to starting work in June and continuing the transformation of the business."

 

Laurence Vaughan, Chairman of Idox said:

"The major review and actions taken reflect our commitment to deal decisively with the issues faced by the Group during the last year. Despite the impact on our financial performance this year, this necessary programme of change has positioned the group to deliver an improved performance in future financial years. 

 

"I believe that the Group has good growth opportunities through its continued focus on digital transformation and high quality governance solutions for the public sector. With new leadership in place we can look forward to the future with renewed confidence."

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

 

Enquiries:

 

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Chairman

Richard Kellett-Clarke, Interim Chief Executive Officer

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare / Charlie Barker

 

For more information see www.idoxplc.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFKCDQABKKPPB
Date   Source Headline
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights
27th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSYear End Trading Update
9th Nov 202310:25 amRNSHolding(s) in Company
6th Nov 20233:01 pmRNSHolding(s) in Company
2nd Nov 20232:10 pmRNSHolding(s) in Company
2nd Nov 202310:09 amRNSHolding(s) in Company
1st Nov 202311:48 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAdoption of New LTIP and Grant of Options
4th Oct 20237:00 amRNSExercise of Share Options & Total Voting Rights
25th Sep 202310:06 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSExercise of Share Options & Total Voting Rights
31st Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
21st Aug 20237:00 amRNSAcquisition
4th Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
3rd Aug 20231:49 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSChange of Registered Address
14th Jul 20237:00 amRNSExercise of Share Options & Total Voting Rights
27th Jun 20237:00 amRNSExercise of Share Options & Total Voting Rights
13th Jun 20237:00 amRNSPayment of Earnout and Allotment of Shares
12th Jun 20234:44 pmRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf Year results
18th May 20237:00 amRNSHalf Year 2023 Trading Update
23rd Mar 20232:33 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Trading Update
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
15th Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
9th Feb 202311:03 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSNotice of Final Results
15th Dec 20227:00 amRNSPayment of Earnout and Allotment of Shares
8th Dec 20221:17 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSTrading Statement
14th Nov 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.